1. Home
  2. GOVX vs TAOP Comparison

GOVX vs TAOP Comparison

Compare GOVX & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

N/A

Current Price

$0.17

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

TAOP

Taoping Inc.

N/A

Current Price

$0.35

Market Cap

3.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GOVX
TAOP
Founded
2001
1993
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
3.1M
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
GOVX
TAOP
Price
$0.17
$0.35
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 111.0K
28.1K
Earning Date
11-12-2026
09-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,489,145.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.17
$0.29
52 Week High
$1,425.00
$3.13

Technical Indicators

Market Signals
Indicator
GOVX
TAOP
Relative Strength Index (RSI) 8.96 36.86
Support Level N/A $0.29
Resistance Level $8.64 $0.37
Average True Range (ATR) 0.16 0.04
MACD -0.15 0.01
Stochastic Oscillator 0.00 36.34

Price Performance

Historical Comparison
GOVX
TAOP

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-based technology solutions, smart city IoT platforms, digital advertising delivery systems, and internet-based information distribution systems in China. The company has three reportable segments. The Cloud-based Technology segment includes cloud-based products, high-end data storage servers, advertising services, and customized software solutions for private sector customers. The Traditional Information Technology segment includes project-based technology products and services sold to the public sector, including Geographic Information Systems, Digital Public Security Technology, and Digital Hospital Information Systems. The Smart Elevator segment provides elevator sales, installation, maintenance, renovation, and cloud-based maintenance services.

Share on Social Networks: